MAPT and juvenile Huntington disease: Given all this, there is still debate surrounding the question of whether tau aggregates and their level of phosphorylation affect the expression and/or progression of Huntington’s disease (Hernández and Avila, 2008; Caparros-Lefebvre et al., 2009).